124 related articles for article (PubMed ID: 978659)
1. Mechanisms of antitumor action of Corynebacterium parvum: the generation of cell-mediated tumor specific immunity.
Tuttle RL; North RJ
J Reticuloendothel Soc; 1976 Sep; 20(3):197-208. PubMed ID: 978659
[No Abstract] [Full Text] [Related]
2. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity.
Tuttle RL; North RJ
J Reticuloendothel Soc; 1976 Sep; 20(3):209-16. PubMed ID: 1086362
[No Abstract] [Full Text] [Related]
3. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
Miyata H
Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
[No Abstract] [Full Text] [Related]
4. Cell mediated immunity to Corynebacterium parvum and its role in tumor control.
Tuttle RL
Dev Biol Stand; 1977 Apr 13-15; 38():189-93. PubMed ID: 608505
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunotherapy of newly induced murine sarcomas.
Shu SY; Rosenberg SA
Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
[TBL] [Abstract][Full Text] [Related]
7. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
8. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
Mazureka C; Stiffel C; Chalvet H; Biozzi G
C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
[TBL] [Abstract][Full Text] [Related]
10. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
[TBL] [Abstract][Full Text] [Related]
11. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
[TBL] [Abstract][Full Text] [Related]
12. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
13. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
Mazurek C; Stiffel C; Chalvet H; Biozzi G
Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
[TBL] [Abstract][Full Text] [Related]
14. Conditions favouring the selection of either specific or non specific C. parvum-mediated, systemic antitumour immunity in mice.
Scott MT
Dev Biol Stand; 1977 Apr 13-15; 38():273-6. PubMed ID: 415921
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
Dye ES; North RJ; Mills CD
J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
17. Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.
Tuttle RL; North RJ
J Natl Cancer Inst; 1975 Dec; 55(6):1403-11. PubMed ID: 1206760
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
19. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
Miyata H; Nomoto K; Takeya K
Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
[TBL] [Abstract][Full Text] [Related]
20. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
